Skip to main content

Table 5 Cox regression analysis of risk factors for END

From: Variants in clopidogrel-relevant genes and early neurological deterioration in ischemic stroke patients receiving clopidogrel

Factor

HR

95% CI

P value

Age

0.82

0.59–1.28

0.476

Diabetes mellitus

1.67

0.92–2.13

0.135

Hemoglobin A1C

1.08

0.88–2.36

0.198

Fasting blood glucose

0.97

0.82–1.86

0.395

AA-induced platelet aggregation

0.73

0.72–1.69

0.512

ADP-induced platelet aggregation

0.78

0.76–1.83

0.438

CYP2C19rs4244285AA/AG

2.41

1.27–6.82

0.005

High-risk interactive variable

2.82

1.36–7.76

0.003

  1. END early neurological deterioration, HR hazard ratio, CI confidence interval
  2. HR for continuous variables means per 1-Standard Deviation increase